Related Experiment Video
Updated: Aug 15, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Cefotetan in complicated urinary tract infections--clinical experience
Abstract:
Cefotetan was evaluated to determine the efficacy and safety of a 1 g dose administered intravenously twice daily in the treatment of complicated urinary tract infections (UTI). Sixty patients entered and 58 patients completed the study. Duration of treatment ranged from 7 to 16 days with a mean of 10.1 days. A satisfactory clinical response was observed in 85%. Eradication of the infecting organisms was prompt and complete in 45 patients. Relapse, reinfection or superinfection occurred in seven patients and in six patients the infecting organisms did not respond to treatment. Cefotetan was well tolerated but two patients had treatment withdrawn because of macular rash. It is concluded that cefotetan is highly effective in treating complicated UTIs.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test

